There was however no significant treatment interaction between MARCO+ and adjuvant chemotherapy (HR = 1.65 95% CI 0.72–3.79 for untreated vs HR = 8.46 95% CI 0.98–73.10, pinteraction = 0.165) in I-type tumours. The gene discussed is MARCO; the disease is neoplasm.